(Q43478375)

23 November 2017

title

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis (English)

1 reference

primary biliary cholangitis

23 November 2017

0 references

1 reference

0 references

author

Pietro Invernizzi

1

1 reference

23 November 2017

Pier Maria Battezzati

3

1 reference

23 November 2017

8

1 reference

ORCID Public Data File 2021

23 November 2017

1 reference

author name string

Podda M

2

1 reference

23 November 2017

Crosignani A

4

1 reference

23 November 2017

Zuin M

5

1 reference

23 November 2017

Hitchman E

6

1 reference

23 November 2017

Maggioni M

7

1 reference

23 November 2017

Penner E

9

1 reference

23 November 2017

Wesierska-Gadek J

10

1 reference

23 November 2017

publication date

1 March 2001

1 reference

23 November 2017

published in

Journal of Hepatology

1 reference

23 November 2017

volume

34

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

366-372

1 reference

Primary biliary cirrhosis

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Autoantibodies against "nuclear dots" in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Nuclear envelope protein autoantibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Two Nuclear Dot‐Associated Proteins, PML and SplOO, are Often Co‐Autoimmunogenic in Patients with Primary Biliary Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Prognosis in primary biliary cirrhosis: model for decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

A modified procedure for the isolation of a pore complex-lamina fraction from rat liver nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Serum immunoglobulins and organ non-specific antibodies in diseases of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

Autoantibodies and autoimmunity: a three-decade perspective. A tribute to Henry G. Kunkel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900040-4

7 January 2021

10.1016/S0168-8278(00)00040-4

Identifiers

DOI

1 reference

release_vsdv2awiafaklafzg3j3hnogvy

23 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vsdv2awiafaklafzg3j3hnogvy

24 November 2022

mapped directly with Wikidata item

1 reference